Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 15326 - 15350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Bortezomib	Approved Investigational	NAP1L2	4674	upregulated	Bortezomib results in increased expression of NAP1L2 mRNA	Xq13.2	A21434
Bortezomib	Approved Investigational	NAT6	24142	downregulated	Bortezomib results in decreased expression of NAT6 mRNA	3p21.31	A21437
Bortezomib	Approved Investigational	NCF4	4689	downregulated	Bortezomib results in decreased expression of NCF4 mRNA	22q12.3	A21434
Bortezomib	Approved Investigational	NCKAP1	10787	upregulated	Bortezomib results in increased expression of NCKAP1 mRNA	2q32.1	A21434
Bortezomib	Approved Investigational	NCOA3	8202	upregulated	Bortezomib results in increased expression of NCOA3 mRNA	20q13.12	A21434
Bortezomib	Approved Investigational	NDRG1	10397	upregulated	Bortezomib results in increased expression of NDRG1 mRNA	8q24.22	A21434
Bortezomib	Approved Investigational	NDRG3	57446	downregulated	Bortezomib results in decreased expression of NDRG3 mRNA	20q11.23	A21434
Bortezomib	Approved Investigational	NEAT1	283131	upregulated	Bortezomib results in increased expression of NEAT1 mRNA	11q13.1	A21434
Bortezomib	Approved Investigational	NEDD1	121441	upregulated	Bortezomib results in increased expression of NEDD1 mRNA	12q23.1	A21434
Bortezomib	Approved Investigational	NETO2	81831	downregulated	Bortezomib results in decreased expression of NETO2 mRNA	16q12.1	A21434
Bortezomib	Approved Investigational	NFIA	4774	downregulated	Bortezomib results in decreased expression of NFIA mRNA	1p31.3	A21434
Bortezomib	Approved Investigational	NFKB1	4790	downregulated	Bortezomib results in decreased expression of NFKB1 mRNA	4q24	A21451
Bortezomib	Approved Investigational	NFKB2	4791	downregulated	Bortezomib results in decreased expression of NFKB2 mRNA	10q24.32	A21451
Bortezomib	Approved Investigational	NFKBIA	4792	upregulated	Bortezomib results in increased expression of NFKBIA mRNA	14q13.2	A21438
Bortezomib	Approved Investigational	NFKBIB	4793	upregulated	Bortezomib results in increased expression of NFKBIB mRNA	19q13.1	A21434 A21451
Bortezomib	Approved Investigational	NFYC	4802	downregulated	Bortezomib results in decreased expression of NFYC mRNA	1p34.2	A21434
Bortezomib	Approved Investigational	NIPSNAP1	8508	downregulated	Bortezomib results in decreased expression of NIPSNAP1 mRNA	22q12.2	A21434
Bortezomib	Approved Investigational	NLRP12	91662	upregulated	Bortezomib results in increased expression of NLRP12 mRNA	19q13.42	A20714
Bortezomib	Approved Investigational	NLRP3	114548	downregulated	Bortezomib results in decreased expression of NLRP3 mRNA	1q44	A21437
Bortezomib	Approved Investigational	NOTCH2	4853	downregulated	Bortezomib results in decreased expression of NOTCH2 mRNA	1p12	A21434
Bortezomib	Approved Investigational	NPTX1	4884	downregulated	Bortezomib results in decreased expression of NPTX1 mRNA	17q25.3	A21434
Bortezomib	Approved Investigational	NQO1	1728	upregulated	Bortezomib results in increased expression of NQO1 mRNA	16q22.1	A21434
Bortezomib	Approved Investigational	NQO2	4835	upregulated	Bortezomib results in increased expression of NQO2 mRNA	6p25.2	A21434
Bortezomib	Approved Investigational	NR1H3	10062	downregulated	Bortezomib results in decreased expression of NR1H3 mRNA	11p11.2	A21434
Bortezomib	Approved Investigational	NT5C2	22978	upregulated	Bortezomib results in increased expression of NT5C2 mRNA	10q24.32-q24.33	A21434

Displaying entries 15326 - 15350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability